Press release article from our research archive:
|
|
Ritalin (R) LA, a New Once-Daily Treatment for ADHD, Receives FDA Approvable Letter.
- Article from:
-
PR Newswire
- Article date:
-
October 2, 2001
|
Copyright informationCOPYRIGHT 2001 PR Newswire Association, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
EAST HANOVER, N.J., and WARREN, N.J., Oct. 2 /PRNewswire/ --
Novartis Pharmaceuticals Corporation and Celgene Corporation announced today that they received an approvable letter from the U.S. Food and Drug Administration (FDA) for Ritalin (R) LA (methylphenidate HCl extended-release capsules) for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Ritalin LA is a new, once-daily formulation of Ritalin (R) (methylphenidate HCl), which eliminates the need for a mid-day dose during school.
An approvable letter usually represents the final step before a product receives FDA clearance for marketing in the United States. Ritalin LA is part of a broad ...
Related newspaper, magazine, and journal articles:
|
Ritalin LA, a new once-daily treatment for ADHD, receives FDA approvable...
M2 Presswire;
October 3, 2001 ;
700+ words
......Corporation and Celgene Corporation announced today...Administration (FDA) for Ritalin LA (methylphenidate...United States. Ritalin LA is part of a...Novartis and Celgene Corporation encompassing...to 12 years. Ritalin LA will offer physicians...Operating ...
|
|
New Study Points to Important Differences Between Long-Acting ADHD...
Ascribe Higher Education News Service;
March 13, 2003 ;
700+ words
......comparing the pharmacokinetic profiles of Ritalin LA(r) (methylphenidate HCl) extended-release...methylphenidate HCl) demonstrate that Ritalin LA exhibits more rapid initial absorption...We found that compared to Concerta, Ritalin LA more closely resembled twice-daily dosing...
|
|
Novartis Pharmaceuticals Corporation. (Product News).(Elan Corporation...
Medical Marketing & Media;
July 1, 2002 ;
40 words
...Novartis Pharmaceuticals Corporation, Elan Corporation plc, and Celgene Corporation have announced FDA marketing clearance for Ritalin LA (methylphenidate HCI) extended-release capsules for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
|
|
Celgene Corporation Announces Third Quarter Results.
PR Newswire;
October 24, 2002 ;
700+ words
......Phase I Clinical Trial Celgene Corporation announced today that THALOMID...Chief Executive Officer of Celgene Corporation. We look forward to announcing...hyperactivity disorder (ADD/ADHD). Ritalin LA joins the Novartis ADD...Novartis initiated REAP (Ritalin LA Early ...
|
|
Ritalin's revival: the Novartis marketing team handling the launch of...
Medical Marketing & Media;
August 1, 2003 ;
700+ words
...The dilemma facing the Ritalin LA launch team was sufficiently unique...solved was how to position Focalin and Ritalin LA (they were launched within seven...each other: Focalin in January 2002, Ritalin LA in August 2002), so that they didn...
|
|
Newer extended-release ADHD drugs look good: Start low, go slow to...
Pediatric News;
December 1, 2001 ;
700+ words
......weeklong titration to optimal dosing of Ritalin LA followed by a 1-week placebo washout...double-blind fashion to either once-daily Ritalin LA or placebo for 2 weeks, Dr. Joseph Biederman...improvements in ADHD symptoms in the Ritalin LA group compared with placebo. The two...
|
|
Celgene Corporation Reconfirms Plans to Submit NDAs For Use of Thalidomide...
PR Newswire;
November 11, 1996 ;
207 words
...WARREN, N.J., Nov. 11 /PRNewswire/ -- Celgene Corporation (Nasdaq: CELG) today reconfirmed...an NDA in this indication also. Celgene Corporation, headquartered in Warren, N.J...pharmaceutical and allied industries. SOURCE Celgene Corporation -0- 11/11/96 /CONTACT: Bryan P...
|
|
Complete and comprehensive analysis of Celgene Corporation.
M2 Presswire;
March 4, 2008 ;
310 words
......and comprehensive analysis of Celgene Corporation(C)1994-2008 M2 COMMUNICATIONS...announced the addition of Analysis of Celgene Corporation to their offering Analysis of Celgene Corporation. A complete and comprehensive...
|
|
Celgene Corporation Launches Clinical Trials For New Class of TNF-alpha...
PR Newswire;
September 29, 1997 ;
444 words
......N.J., Sept. 29 /PRNewswire/ -- Celgene Corporation (Nasdaq: CELG) announced today that...patents related to SelCID worldwide. Celgene Corporation uses proprietary expertise in small...and Exchange Commission. SOURCE Celgene Corporation -0- 09/29/97 /CONTACT: Robert C...
|
|
Celgene Corporation Files Registration Statement
PR Newswire;
November 26, 1997 ;
134 words
...WARREN, N.J., Nov. 26 /PRNewswire/ -- Celgene Corporation (Nasdaq: CELG) today announced a...at a price of $9.00 per share. Celgene Corporation, located in Warren, NJ is engaged...telephone number 212-906-7000. SOURCE Celgene Corporation -0- 11/26/97 /CONTACT: Robert C...
|
|
Celgene Corporation Elects Robert J. Hugin to Its Board of Directors.
PR Newswire;
December 4, 2001 ;
258 words
......J. -- The Board of Directors of Celgene Corporation has elected Robert J. Hugin to the...Chairman and Chief Executive Officer of Celgene Corporation. He plays an integral role in the...the United States Marine Corps. Celgene Corporation, located in Warren, New Jersey...
|
|
R.G. WRIGHT TO RETIRE FROM POSTS AS CHAIRMAN AND CHIEF EXECUTIVE OF...
PR Newswire;
September 26, 1995 ;
253 words
......chairman and chief executive officer of Celgene Corporation (Nasdaq: CELG), has notified the...a $12 million private placement. Celgene Corporation, headquartered in Warren, NJ, uses...G. Wright, Chairman & CEO of Celgene Corporation, 908-271-4119; or Thomas Redington...
|
See all results.
Or, try our
Advanced Search.
|